Campbell & Co. Investment Adviser »

Mirati Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.4M 32k 43.56
2022-06-30 $440k 6.6k 67.10
2022-03-31 $323k 3.9k 82.33

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Mirati Therapeutics

venBio Select Advisor
Sawtooth Asset Management
Hsbc Holdings
Alliancebernstein
National Bank Of Canada /fi/
Madison Avenue Partners
Healthcare Of Ontario Pension Plan Trust Fund
Sand Grove Capital Management
Bank of Nova Scotia
Alberta Investment Management Corporation
Kellner Capital
Guggenheim Capital, LLC Managers
Algert Coldiron Investors
IFP Advisors
Federated Investors

View all funds holding Mirati Therapeutics